SKYEPHARMA AND MUNDIPHARMA ANNOUNCE EXCLUSIVE LICENCE AGREEMENT FOR MARKETING AND DISTRIBUTION OF FLUTIFORM(TM) IN EUROPE

SkyePharma PLC announces that it has entered into an agreement with Mundipharma International Corporation Limited ("Mundipharma") for the development, marketing and distribution in Europe and certain other international markets of Flutiform, its novel combination product for asthma and chronic obstructive pulmonary disease ("COPD"). Yahoo Finance (http://biz.yahoo.com/prnews/060906/nyw131.html?.v=68)